Asthma
📧 Sign up to get email alerts when something new happens for Asthma.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2008-10-10FDA Approved: ALVESCO — Supplemental Application (Covis Pharma US, Inc)
The FDA approved Covis Pharma US's supplemental application for Alvesco (ciclesonide), resulting in changes to the product labeling.
-
CLINICAL_TRIALS trial_result · 2008-09-25Clinical Trial Update: NIS for Patients Using Symbicort Turbuhaler for Maintenance and Reliever Therapy in a Single Inhaler
This document reports the completion of a non-interventional study evaluating the use of Symbicort Turbuhaler as maintenance and reliever th…
-
CLINICAL_TRIALS trial_result · 2008-09-23Clinical Trial Update: Study to Evaluate the Impact of Obesity on Airway Inflammation and Mechanics in Asthmatics
This clinical trial evaluated the impact of obesity on airway inflammation and mechanics in asthmatic individuals; the study is now complete…
-
FDA approval · 2008-09-16FDA Approved: IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE — Supplemental Application (Nephron Pharmaceuticals Corporation)
The FDA approved a supplemental application for Nephron Pharmaceuticals Corporation's Ipratropium Bromide and Albuterol Sulfate product.
-
FDA approval · 2008-09-16FDA Approved: ALBUTEROL SULFATE HFA — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for ALBUTEROL SULFATE HFA by Teva Pharmaceuticals USA, Inc., updating the product label through a su…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-09-05Clinical Trial Update: Nebulizer Intervention for Minority Children With Asthma [Phase 3]
Phase 3 trial evaluating a nebulizer intervention for asthma in minority children has completed.
-
CLINICAL_TRIALS research · 2008-09-05Clinical Trial Update: Teaching Children With Asthma and Who Live in a Rural Setting How to Self-Manage Their Asthma [Phase 3]
Phase 3 clinical trial update on teaching rural-dwelling children with asthma to self-manage their condition. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2008-09-04Clinical Trial Update: Safety Study of Anti-Asthma Agent BMEC-1217B [Phase 1]
Phase 1 safety study of the anti-asthma agent BMEC-1217B conducted by Medigreen Biotechnology Corp. for asthma; the study status is currentl…
-
FDA approval · 2008-08-27FDA Approved: VENTOLIN HFA — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for Ventolin HFA (albuterol sulfate) submitted by GlaxoSmithKline LLC. The approval covers the chang…
-
CLINICAL_TRIALS trial_result · 2008-08-26Clinical Trial Update: Asthma in the Delta Region of Arkansas (ADRA): Prevalence and Morbidity
A completed clinical trial from Arkansas Children's Hospital Research Institute assessed the prevalence and morbidity of asthma in the Delta…
-
CLINICAL_TRIALS trial_result · 2008-08-25Clinical Trial Update: Allergy and Asthma Following Children Who Were Fed Supplemented Infant Formula
This document reports the completion of a clinical trial evaluating whether feeding children with supplemented infant formula influences all…
-
CLINICAL_TRIALS trial_result · 2008-08-21Clinical Trial Update: Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent Asthma [Phase 3]
A Phase 3 trial assessed the efficacy and safety of fexofenadine for mild-to-moderate persistent asthma. The study has completed.
-
CLINICAL_TRIALS trial_result · 2008-08-21Clinical Trial Update: Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent Asthma [Phase 3]
Phase 3 trial evaluating the efficacy and safety of fexofenadine in patients with mild to moderate persistent asthma. The study has complete…
-
CLINICAL_TRIALS trial_result · 2008-08-21Clinical Trial Update: Effect of Salmeterol on Brain-Derived Neurotrophic Factor (BDNF) Concentrations in Asthma [NA]
A completed clinical trial evaluating the effect of salmeterol on Brain-Derived Neurotrophic Factor (BDNF) concentrations in patients with a…
-
CLINICAL_TRIALS trial_result · 2008-08-21Clinical Trial Update: Long-Term Safety Performance of Fexofenadine in Asthma [Phase 3]
A Phase 3 study evaluating the long-term safety of fexofenadine in patients with asthma has completed.
-
CLINICAL_TRIALS trial_result · 2008-08-21Clinical Trial Update: Measuring Exhaled Nitric Oxide (eNO) Using the Apieron INSIGHT System and the Aerocrine NIOX System
A completed clinical trial comparing the Apieron INSIGHT System and the Aerocrine NIOX System for measuring exhaled nitric oxide in asthma p…
-
CLINICAL_TRIALS trial_result · 2008-08-18Clinical Trial Update: Primary Prevention of Atopic Disease by Perinatal Administration of Probiotics [NA]
A completed clinical trial evaluated whether perinatal administration of probiotics can prevent atopic diseases in children.
-
CLINICAL_TRIALS research · 2008-08-12Clinical Trial Update: Complementary and Alternative Medicine Use in Low-Income African American and Caucasian Adults With Asthma
A ClinicalTrials.gov update indicating that the study on complementary and alternative medicine use among low-income African American and Ca…
-
CLINICAL_TRIALS trial_result · 2008-08-11Clinical Trial Update: Ozone and Rhinovirus-Induced Disease in Asthmatics
A NIEHS-sponsored clinical trial studied how ozone exposure and rhinovirus infection interact to influence asthma symptoms, and the study ha…
-
FDA approval · 2008-07-31FDA Approved: ADVAIR HFA — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for Advair HFA (fluticasone propionate and salmeterol xinafoate) submitted by GlaxoSmithKline LL…
-
FDA approval · 2008-07-28FDA Approved: PROVOCHOLINE — Supplemental Application (Methapharm Inc.)
FDA approves a supplemental application for PROVOCHOLINE (methacholine chloride inhalation solution) by Methapharm Inc.
-
CLINICAL_TRIALS research · 2008-07-25Clinical Trial Update: Social-Economics Profile of the Asthmatic Patients Attended at Nucleus of Integrated Medical Care
Clinical trial completed; the study evaluated the social-economic profile of patients with asthma attending care at Nucleus of Integrated Me…
-
FDA approval · 2008-07-21FDA Approved: FLUTICASONE PROPIONATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved Hikma Pharmaceuticals USA Inc.'s supplemental application for Fluticasone Propionate, approving an updated or additional ge…
-
CLINICAL_TRIALS trial_result · 2008-07-17Clinical Trial Update: Improving Asthma Communication in Minority Families [Phase 2]
Phase 2 clinical trial evaluating an intervention to improve asthma communication in minority families has completed.
-
FDA approval · 2008-07-16FDA Approved: BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for budesonide and formoterol fumarate dihydrate (Symbicort) from AstraZeneca Pharmaceuticals LP.